YU48200A - Farmaceutski preparati - Google Patents
Farmaceutski preparatiInfo
- Publication number
- YU48200A YU48200A YU48200A YU48200A YU48200A YU 48200 A YU48200 A YU 48200A YU 48200 A YU48200 A YU 48200A YU 48200 A YU48200 A YU 48200A YU 48200 A YU48200 A YU 48200A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- pharmaceutical compositions
- purin
- cyclopropylamino
- cyclopentene
- cis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Ovaj pronalazak se odnosi na farmaceutske preparate (1S,4R)-cis-4-[2-amino-6-(ciklopropilamino)-9H-purin-9-il]-2-ciklopenten-1-metanola (1592U89).[The present invention relates to pharmaceutical compositions of (1S,4R)-cis-4- [2-amino- 6- cyclopropylamino)- 9H-purin-9- il]-2-cyclopentene-1-methanol (1592U89).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9802472.2A GB9802472D0 (en) | 1998-02-06 | 1998-02-06 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU48200A true YU48200A (sh) | 2003-02-28 |
| RS49953B RS49953B (sr) | 2008-09-29 |
Family
ID=10826520
Country Status (39)
| Country | Link |
|---|---|
| US (1) | US6641843B1 (sh) |
| EP (1) | EP1051156B1 (sh) |
| JP (1) | JP3560550B2 (sh) |
| KR (1) | KR100564854B1 (sh) |
| CN (2) | CN101239063A (sh) |
| AP (1) | AP1212A (sh) |
| AR (1) | AR017455A1 (sh) |
| AT (1) | ATE237309T1 (sh) |
| AU (1) | AU754255B2 (sh) |
| BR (1) | BR9907649A (sh) |
| CA (1) | CA2319010C (sh) |
| CO (1) | CO5070673A1 (sh) |
| CZ (1) | CZ299608B6 (sh) |
| DE (1) | DE69906934T2 (sh) |
| DK (1) | DK1051156T3 (sh) |
| EA (1) | EA002916B1 (sh) |
| EE (1) | EE04217B1 (sh) |
| ES (1) | ES2196779T3 (sh) |
| GB (1) | GB9802472D0 (sh) |
| HK (1) | HK1030552A1 (sh) |
| HR (1) | HRP20000530B1 (sh) |
| HU (1) | HU228315B1 (sh) |
| ID (1) | ID26215A (sh) |
| IL (2) | IL137403A0 (sh) |
| IS (1) | IS2200B (sh) |
| MA (1) | MA26604A1 (sh) |
| MY (1) | MY121043A (sh) |
| NO (1) | NO329041B1 (sh) |
| NZ (1) | NZ505811A (sh) |
| PE (1) | PE20000271A1 (sh) |
| PL (1) | PL194558B1 (sh) |
| PT (1) | PT1051156E (sh) |
| RS (1) | RS49953B (sh) |
| SI (1) | SI1051156T1 (sh) |
| SK (1) | SK284397B6 (sh) |
| TR (1) | TR200002293T2 (sh) |
| TW (1) | TWI222878B (sh) |
| WO (1) | WO1999039691A2 (sh) |
| ZA (1) | ZA99890B (sh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2080511A3 (en) * | 2000-08-22 | 2009-09-30 | Shire LLC | Active agent delivery systems and methods for protecting and administering active agents |
| US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
| US7169752B2 (en) | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
| EP2085397A1 (en) * | 2008-01-21 | 2009-08-05 | Esteve Quimica, S.A. | Crystalline form of abacavir |
| EP2305680A3 (en) * | 2009-09-30 | 2011-05-18 | Aurobindo Pharma Limited | Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol |
| CN104788451A (zh) * | 2014-01-21 | 2015-07-22 | 浙江九洲药业股份有限公司 | 一种阿巴卡韦的制备方法 |
| CN105315280A (zh) * | 2014-06-06 | 2016-02-10 | 上海迪赛诺化学制药有限公司 | 一种阿巴卡韦结晶体及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5631370A (en) | 1988-01-20 | 1997-05-20 | Regents Of The University Of Minnesota | Optically-active isomers of dideoxycarbocyclic nucleosides |
| US5567703A (en) | 1988-01-20 | 1996-10-22 | Regents Of The University Of Minnesota | Method for treating HIV infections with dideoxycarbocyclic nucleosides |
| GB8815265D0 (en) | 1988-06-27 | 1988-08-03 | Wellcome Found | Therapeutic nucleosides |
| MY104575A (en) | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
| GB9417249D0 (en) * | 1994-08-26 | 1994-10-19 | Wellcome Found | A novel salt |
| IL127350A0 (en) * | 1996-06-25 | 1999-10-28 | Glaxo Group Ltd | Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV |
| US6124319A (en) * | 1997-01-21 | 2000-09-26 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
| US6177464B1 (en) * | 1997-03-14 | 2001-01-23 | Sepracor, Inc. | Ring opening metathesis of alkenes |
| GB9709945D0 (en) | 1997-05-17 | 1997-07-09 | Glaxo Group Ltd | A novel salt |
-
1998
- 1998-02-06 GB GBGB9802472.2A patent/GB9802472D0/en not_active Ceased
-
1999
- 1999-02-02 TW TW088101534A patent/TWI222878B/zh not_active IP Right Cessation
- 1999-02-03 PE PE1999000088A patent/PE20000271A1/es not_active IP Right Cessation
- 1999-02-03 AR ARP990100439A patent/AR017455A1/es active IP Right Grant
- 1999-02-04 CO CO99006407A patent/CO5070673A1/es unknown
- 1999-02-04 EE EEP200000459A patent/EE04217B1/xx unknown
- 1999-02-04 US US09/601,671 patent/US6641843B1/en not_active Expired - Lifetime
- 1999-02-04 KR KR1020007008595A patent/KR100564854B1/ko not_active IP Right Cessation
- 1999-02-04 CZ CZ20002867A patent/CZ299608B6/cs not_active IP Right Cessation
- 1999-02-04 PT PT99907477T patent/PT1051156E/pt unknown
- 1999-02-04 EA EA200000736A patent/EA002916B1/ru not_active IP Right Cessation
- 1999-02-04 ZA ZA9900890A patent/ZA99890B/xx unknown
- 1999-02-04 CA CA002319010A patent/CA2319010C/en not_active Expired - Lifetime
- 1999-02-04 ES ES99907477T patent/ES2196779T3/es not_active Expired - Lifetime
- 1999-02-04 HU HU0100802A patent/HU228315B1/hu unknown
- 1999-02-04 SK SK1168-2000A patent/SK284397B6/sk not_active IP Right Cessation
- 1999-02-04 RS YUP-482/00A patent/RS49953B/sr unknown
- 1999-02-04 DK DK99907477T patent/DK1051156T3/da active
- 1999-02-04 CN CNA2008100838827A patent/CN101239063A/zh active Pending
- 1999-02-04 JP JP2000530191A patent/JP3560550B2/ja not_active Expired - Lifetime
- 1999-02-04 WO PCT/EP1999/000663 patent/WO1999039691A2/en active IP Right Grant
- 1999-02-04 DE DE69906934T patent/DE69906934T2/de not_active Expired - Lifetime
- 1999-02-04 EP EP99907477A patent/EP1051156B1/en not_active Expired - Lifetime
- 1999-02-04 MA MA25452A patent/MA26604A1/fr unknown
- 1999-02-04 NZ NZ505811A patent/NZ505811A/xx not_active IP Right Cessation
- 1999-02-04 MY MYPI99000389A patent/MY121043A/en unknown
- 1999-02-04 AP APAP/P/2000/001878A patent/AP1212A/en active
- 1999-02-04 CN CN99804843A patent/CN1296406A/zh active Pending
- 1999-02-04 ID IDW20001507A patent/ID26215A/id unknown
- 1999-02-04 TR TR2000/02293T patent/TR200002293T2/xx unknown
- 1999-02-04 AT AT99907477T patent/ATE237309T1/de active
- 1999-02-04 AU AU27221/99A patent/AU754255B2/en not_active Expired
- 1999-02-04 PL PL99342628A patent/PL194558B1/pl unknown
- 1999-02-04 IL IL13740399A patent/IL137403A0/xx active IP Right Grant
- 1999-02-04 SI SI9930271T patent/SI1051156T1/xx unknown
- 1999-02-04 BR BR9907649-7A patent/BR9907649A/pt not_active Application Discontinuation
-
2000
- 2000-07-19 IL IL137403A patent/IL137403A/en not_active IP Right Cessation
- 2000-07-20 IS IS5569A patent/IS2200B/is unknown
- 2000-08-04 NO NO20003962A patent/NO329041B1/no not_active IP Right Cessation
- 2000-08-04 HR HR20000530A patent/HRP20000530B1/xx not_active IP Right Cessation
-
2001
- 2001-03-06 HK HK01101617A patent/HK1030552A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW272195B (sh) | ||
| MY134136A (en) | Novel compounds comprising jak3 kinase inhibitors | |
| AU3652102A (en) | Compounds and their uses | |
| IL150257A0 (en) | Galactomaninan oligosaccharides, pharmaceutical compositions containing the same and methods for the production thereof | |
| AU2003228770A1 (en) | Substituted pyrazolopyrimidines | |
| JO2034B1 (en) | Isotopes of the hormone peptide its uses and the chemical compounds it contains | |
| AU2002220715A1 (en) | Indolsulfonyl compounds useful in the treatment of cns disorders | |
| NZ527867A (en) | Oral pharmaceutical composition of cefpodoxime proxetil | |
| ZA200203102B (en) | Novel oligosaccharides, preparation method and pharmaceutical compositions containing same. | |
| IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| CA2335551A1 (en) | Thyroid hormone analogues and methods for their preparation | |
| EP0980864A3 (en) | Sulphonamide derivatives | |
| AU5239999A (en) | Heterocyclyl sulphonamide derivatives | |
| YU48200A (sh) | Farmaceutski preparati | |
| DE19780262D2 (de) | Harpagosid- | |
| CA2344686A1 (en) | High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
| AU2002248531A1 (en) | Pyrazolopyriadine derivatives | |
| BG102229A (en) | Endothelium receptor antagonists | |
| AU7028798A (en) | Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent | |
| WO1998034949A3 (en) | Monocyclic compounds with four bifunctional residues having nk-2 antagonist action | |
| AU2910800A (en) | Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines | |
| ECSP992846A (es) | Composiciones farmaceuticas | |
| MX9701865A (es) | Compuestos de dimetil-(3-aril-but-3-enil)-amino como ingredientes activos farmaceuticos. |